Entering text into the input field will update the search result below

Taro Pharmaceutical EPS of $2.10

  • Taro Pharmaceutical (NYSE:TARO): FQ4 EPS of $2.10.
  • Revenue of $187.2M (+13.3% Y/Y).
  • Press Release

Recommended For You

About TARO Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
TARO--
Taro Pharmaceutical Industries Ltd.